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Background: Further insight into structural 
biology of TRP channels is crucial to explain 
molecular mechanisms of channel function. 
Results: We purified TRPV3, demonstrate its 
functional integrity and use fluorescence 
spectroscopy to study ligand binding. 
Conclusion: TRPV3 ligands induce different 
conformational changes as observed by tryptophan 
fluorescence quenching. 
Significance: Availability of purified TRPV3 
allows functional assays outside the cellular 
context and facilitates future structural studies. 
 
ABSTRACT 
TRPV3 is a thermosensitive ion channel 
primarily expressed in epithelial tissues of the 
skin, nose and tongue. The channel has been 
implicated in environmental thermosensation, 
hyperalgesia in inflamed tissues, skin 
sensitization and hair growth. While TRP 
channel research has vastly increased our 
understanding of the physiological mechanisms 
of nociception and thermosensation, the 
molecular mechanics of these ion channels are 
still largely elusive. In order to better 
comprehend the functional properties and the 
mechanism of action in TRP channels, high-
resolution 3-D structures are indispensible, as 
they will yield the necessary insights into 
architectural intimacies at the atomic level. 
However, structural studies of membrane 
proteins are currently hampered by difficulties 
in protein purification and establishing suitable 
crystallization conditions. 
In this report, we present a novel protocol 
for the purification of membrane proteins, 
which takes advantage of a C-terminal green 
fluorescent protein (GFP) fusion. Using this 
protocol, we purified human TRPV3. We show 
that the purified protein is a fully functional ion 
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channel with properties akin to the native 
channel using planar patch clamp on 
reconstituted channels and intrinsic tryptophan 
fluorescence spectroscopy. Using intrinsic 
tryptophan fluorescence spectroscopy, we 
reveal clear distinctions in the molecular 
interaction of different ligands with the 
channel. 
Altogether, this study provides powerful 
tools to broaden our understanding of ligand 
interaction with TRPV channels and the 
availability of purified human TRPV3 opens up 
perspectives for further structural and 
functional studies. 
 
Transient Receptor Potential (TRP) channels 
constitute a large family of transmembrane 
proteins that form tetrameric cation-permeable 
channels (1). TRPV3 is a member of the TRPV 
(TRP vanilloid) family and belongs to the 
temperature-sensitive TRP channels (so-called 
“thermo-TRPs”), showing strong activation by 
warming in the thermal range of 33–39 °C. The 
channel is expressed robustly in keratinocytes of 
the skin, tongue and nose and is also present in 
peripheral sensory neurons in humans (2-4). 
Because of this expression pattern and temperature 
sensitivity, TRPV3 was proposed as a putative 
thermo-sensor. However, it is still unclear at 
present whether TRPV3 is in fact involved in 
acute thermal transduction. Thermosensation is 
thought to be directly mediated by sensory 
neurons of the dorsal root ganglia (DRGs) that 
terminate as free nerve endings in the skin (5-7). 
Initial studies reported that TRPV3-deficient mice 
exhibit clear behavioral deficits in warmth 
sensation (8). However, TRPV3 channels are not 
expressed in DRG neurons in mice and more 
recent studies debate the question whether TRPV3 
plays a direct role in thermosensation (9-11). 
TRPV3 mRNA is also found throughout the brain, 
but its function here remains unknown (3, 4). 
Some studies have indicated TRPV3 to be 
involved in emotional regulation and synaptic 
plasticity (12-16). 
In addition to its temperature sensitivity, TRPV3 is 
also responsive to a number of exogenous ligands, 
including plant-derived terpenoids like camphor, 
menthol and eucalyptol (17-19). Although it is 
tempting to argue that TRPV3 might be involved 
in the anesthetic, analgesic and antipruritic 
properties of these compounds in over-the-counter 
therapeutic products, some caution should be 
taken, as most of these ligands are quite 
promiscuous in their interactions with thermo-
TRPs. For instance, the popular cooling agent 
menthol activates TRPV3, but also TRPM8 and 
TRPA1, two cold-activated thermo-TRPs (20, 21). 
At room temperature, menthol application results 
in a cooling effect, while in warmer environments, 
it produces a warm sensation. It was hypothesized 
that the cold perception may be mediated by 
TRPM8 and the warm perception by TRPV3 (21). 
Icilin, another TRPM8 and TRPA1 agonist and 
super-cooling agent was found to inhibit TRPV3, 
which might contribute to the strong cooling 
perception of the compound (22). 
Until recently, our understanding of TRP channel 
structural biology was limited to either high-
resolution (up to 1.6 Å) X-ray structures from 
cytoplasmic domains of TRP channels, or low-
resolution (up to 19 Å) electron microscopy (EM) 
studies of integral channels (23-30). In a recent 
publication, the 3-D structure of rat TRPV1 was 
solved by cryo-EM with a resolution of at best 3.4 
Å (31, 32). While the reported TRPV1 structures 
in presence and absence of pharmacological 
probes suggest fundamental differences in channel 
gating between TRP channels and typical voltage-
gated channels, the structures still lack sufficient 
atomic detail to answer fundamental questions like 
how and where vanilloid ligands bind to the 
channel, or to explain molecular mechanisms of 
gating in TRP channels. Comparison of the 
TRPV1 EM structure with low-resolution EM 
structures from TRPV2 and TRPV4 reveals a 
shared global architecture within the TRPV family 
(30, 33). It is however clear that high-resolution 
structures of individual full-length TRPV channels 
will be indispensable leads for new testable 
hypotheses to elucidate the molecular frameworks 
that underlie the gating characteristics of specific 
TRPV channels. In particular TRPV3 displays 
some unusual channel properties within the 
vanilloid receptor family (16). For example, 
TRPV3 exhibits a strong sensitization upon 
repeated short-time exposure to heat or chemical 
agonists, in contrast with other TRPV channels 
that desensitize upon repeated activation (2, 4, 34-
36). Moreover, TRPV3 displays an unusually large 
unitary conductance (34) and is potentiated by 
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hydrolysis of the membrane lipid PI(4,5)P2, rather 
than inhibited like most other TRPV channels 
(37). 
In our aim to study molecular mechanisms 
underlying the function of TRPV channels, we 
devised a method for biochemical purification of 
full-length human TRPV3 for structural studies. 
We demonstrate that the detergent-purified protein 
is a functional channel. While crystallization 
efforts for X-ray diffraction are currently ongoing, 
we use detergent-purified TRPV3 to study ligand 
binding in fluorescence spectroscopy experiments. 
 
EXPERIMENTAL PROCEDURES 
Protein expression – For expression in Sf9 insect 
cells (Spodoptera frugiperda), cDNA encoding 
human TRPV3 (hTRPV3) was subcloned into the 
pFastBac vector and baculovirus was produced 
according to the manufacturer’s protocol (Bac-to-
Bac, Invitrogen). The hTRPV3 construct was 
expressed as a fusion protein with a PreScission 
cleavage site, C-terminal GFP and 8xHis tag. Sf9 
cells were harvested 60 h post infection by 
centrifugation (10,000 g for 20 min) and 
resuspended in buffer A (200 mM NaCl, 50 mM 
Tris, pH 7.5), supplemented with 10 µg⋅ml-1 
DNAse, 5 mM MgCl2 and protease inhibitors (1 
mM phenylmethanesulfonyl fluoride, 1 µg⋅ml-1 
pepstatin, 1 µg⋅ml-1 leupeptin and 1 µg⋅ml-1 
aprotinin). The resuspended cells were 
subsequently lyzed by sonication and centrifuged 
(10,000 g for 20 min) to discard unbroken cells. 
Membranes were harvested by ultracentrifugation 
(125,000 g for 1 hour) and resuspended in buffer 
A, supplemented with protease inhibitors (1 ml 
buffer per g membrane). Homogenized 
membranes were sampled in 360-µl aliquots, snap-
frozen in liquid N2 and stored at -80° C until 
further use. 
Detergent screen – Isolated crude membrane 
aliquots were thawed on ice and detergent stock 
was added to a final concentration of 1 or 2% 
(w/v), depending on the critical micelle 
concentration (CMC), with a final concentration at 
≥ 3x CMC. In the screen, most commonly used 
detergents including n-decyl-β-D-maltopyranoside 
(DM), n-undecyl-β-D-maltopyranoside (UDM), n-
dodecyl-β-D-maltopyranoside (DDM), 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propane 
sulfonate (CHAPS), n-octyl-β-D-glucopyranoside 
(OG), lauryl maltose neopentyl glycol (LMNG), n-
dodecyl-N,N-dimethylamine-N-oxide (LDAO), 3-
[(3-cholamidopropyl)-dimethylammonio]-2-
hydroxy-1-propane sulfonate (CHAPSO), n-
decylphosphocholine (Fos-10), n-
dodecylphosphocholine (Fos-12) and n-
tertadecylphosphocholine (Fos-14) were tested 
(Anagrade, Anatrace). Membrane-detergent 
mixtures were rotated for 1 hour at 4 °C for 
solubilization. Insoluble parts were removed by 
ultracentrifugation (1 h at 60,000 g) and 100 µl of 
clear supernatant was injected on a gel filtration 
column (Superose 6 10/300 GL, AKTA purifier 
system, GE Healthcare), coupled to a fluorescence 
detector (RF-10AXL, Shimadzu). The running 
buffer consisted of buffer A, supplemented with 
the respective detergent at a concentration of ~1.5 
x CMC. 
Protein purification – Expression and isolation of 
crude membranes were performed as described 
above. For solubilization, 2% (w/v) DDM and 
0.2% (w/v) CHAPS (anagrade, Affymetrix) were 
added to gently thawed membranes and the sample 
was stirred for 1 h at 4 °C. The solubilizate was 
ultracentrifuged (60,000 g for 1 hour) to discard 
non-solubilized material and protein aggregates. 
The supernatant was incubated for 30 min with 
GPF-nanobody coupled agarose beads (GFP-
Trap_A, Chromotek) at 4 °C. Then the flow-
through was discarded and the beads were washed 
with 10 column volumes (CV) of buffer A, 
supplemented with 0.2% (w/v) DDM and 0.2% 
(w/v) CHAPS. To elute hTRPV3, the fusion 
protein was cleaved off overnight by incubation 
with PreScission protease (0.3 mg⋅ml-1) at 4 °C, 
leaving the GFP–His-tag bound to the beads. The 
total elution (eluate + 5 CV wash) was then 
concentrated to ~1 ml (100 kDa cut-off, Vivaspin 
20, Sartorius) and loaded on a Superose 6 10/300 
GL gel filtration column (AKTA purifier system, 
GE Healthcare). The running buffer consisted of 
buffer B (100 mM NaCl, 10 mM TRIS, pH 7.5), 
supplemented with 0.03% (w/v) DDM and 0.1% 
(w/v) CHAPS. After analysis on SDS-PAGE, the 
peak fractions were compiled and concentrated 
(100 kDa cut-off, Vivaspin 6, Sartorius). 
FSEC-based thermostability assay – Isolated 
crude membrane aliquots were solubilized in the 
presence of 2 % (w/v) DDM. To determine the 
melting temperature (temperature of half-maximal 
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fluorescence amplitude), aliquots of solubilized 
membranes were each heated for 10 min to a 
different temperature in the range of 4–70 °C. The 
aliquots were then centrifuged for 20 min at 
82,000 g and the supernatants were consecutively 
injected on a gel filtration column (Superose 6 
10/300 GL, AKTA purifier system, GE 
Healthcare), coupled to a fluorescence detector 
(RF-10AXL, Shimadzu). A melting curve was 
constructed by plotting the relative fluorescence 
signal of the hTRPV3 peaks (with 4 °C set as 1) 
against the corresponding temperatures. The data 
were fit with a sigmoidal curve using nonlinear 
regression in Prism 6 (GraphPad). To test the 
effect of additives on hTRPV3 thermostability, 
crude membranes were pre-incubated at 4 °C for 
60 min with a variety of salts, lipids, detergents 
and ligands before heating to 40 °C for 10 min. 
This heating temperature was set slightly higher 
than the calculated melting temperature for apo 
hTRPV3 (36 °C), in order to better monitor 
potential stabilizing effects of additives. Detergent 
additives 0.1–1% (w/v) 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propane sulfonate (CHAPS), 
0.15% (v/v) 6-cyclohexyl-1-hexyl-β-D-maltoside 
(Cymal-6), 0.15%  (v/v) 7-Cyclohexyl-1-Heptyl-β-
D-Maltoside (Cymal-7), 0.2% (v/v) n-octyl-β-D-
glucoside (OG), 0.02% (v/v) n-undecyl-β-D-
maltopyranoside (UDM), 0.02% (v/v) n-dodecyl-
N,N-dimethylamine-N-oxide (LDAO), 0.02% 
(v/v) 3-[(3-cholamidopropyl)-dimethylammonio]-
2-hydroxy-1-propane sulfonate (CHAPSO), 0.2% 
(v/v) n-decyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate (zwittergent 3-10) and 0.2% 
(v/v) n-tetradecyl-N,N-dimethyl-3-ammonio-1-
propanesulfonate (zwittergent 3-14) were 
purchased in anagrade quality from Anatrace. 
Lipid additives 0.2 mM 1-hexadecanoyl-2-
octadecenoyl-glycero-3-phosphocholine (POPC), 
0.2 mM 1-palmitoyl-2-oleoyl-glycero-3-
phosphoethanolamine (POPE), 0.2 mM 1-
palmitoyl-2-oleoyl-glycero-3-phospho-(1'-rac-
glycerol)  (POPG), 0.2 mM 1-palmitoyl-2-oleoyl-
glycero-3-phospho-L-serine, sodium salt (POPS), 
0.2 mM 1,2-dioctadecenoyl-glycero-3-phospho-L-
serine, sodium salt (DOPS), 0.2 mM 1,2-
dioctadecenoyl)-glycero-3-phosphocholine 
(DOPC), 0.2 mM 1,2-dioctadecenoyl)-glycero-3-
phosphoethanolamine (DOPE), 0.2 mM 1,2-
ditetradecanoyl-glycero-3-phosphocholine 
(DMPC), 0.2 mM  1,2-dihexadecanoyl-glycero-3-
phosphocholine (DPPC), 0.2 mM 1,2-diheptanoyl-
glycero-3-phosphocholine (DHPC), 0.2 mM  3β-
hydroxy-5-cholestene-3-hemisuccinate (CHEMS), 
0.2 mM 1',3'-bis[1,2-dimyristoylglycero-3-
phospho]-glycerol, sodium salt (cardiolipin), 0.2 
mM D-erythro-sphingosylphosphorylcholine 
(sphingomyelin, porcine brain), 0.2 mM N-
octadecanoyl-D-erythro-sphingosine (ceramide, 
porcine brain) and 0.2 mM 5,8,11,14-cis-
eicosatetraenoylethanolamide (anandamide) were 
purchased from Avanti Lipids. Other tested 
additives 0.1% (v/v) Soybean oil, 1–100 mM 
CaCl2, 100 mM MgCl2, 100 mM ZnCl2, 3 mM 
menthol, 5 mM camphor, 5 mM carvacrol, 1mM 
2-APB and 0.1 mM icilin were purchased from 
Sigma-Aldrich. After heating, the samples were 
centrifuged (20 min at 82,000 g) and the 
supernatants were consecutively injected on a gel 
filtration column (Superose 6 10/300 GL, AKTA 
purifier system, GE Healthcare), coupled to a 
fluorescence detector (RF-10AXL, Shimadzu). For 
comparison, the relative fluorescence signals of 
pre-incubated samples are shown in a bar plot, 
together with the relative fluorescence signal from 
non-pretreated samples at 4 and 40 °C (with 4 °C 
set as 1). 
Microfluorimetric intracellular Ca2+ imaging 
experiments – Sf9 cells were infected with 
baculovirus 36–48 hours before the imaging 
experiments and incubated at 28 °C. Immediately 
prior to the experiment, the cells were incubated 
with 2 µM Fura-2AM ester for 30 min at 28 °C. 
Fluorescence images were acquired at room 
temperature (21–26 °C) on a Cell∧M system 
(Olympus). The fluorescence intensity of 
individual cells was measured at excitation 
wavelengths 340 and 380 nm, and monitored as a 
ratio of the fluorescence at both wavelengths 
(F340/F380) after correction for the background 
fluorescence. Throughout the experiments, cells 
were perfused with standard Krebs solution 
containing 150 mM NaCl, 6 mM KCl, 10 mM 
HEPES, 1.5 mM CaCl2, 1 mM MgCl2, 10 mM 
glucose monohydrate, pH adjusted to 7.4. The data 
were classified semi-automatically using 
MATLAB (MathWorks) and analyzed with Origin 
7.0 (OriginLab). 
Patch clamp recordings on planar lipid bilayers – 
We reconstituted detergent-purified hTRPV3 in 
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lipid bilayers and assayed its functional properties 
using the planar patch clamp technique. The lipid 
bilayers were obtained from Giant Unilamellar 
Vesicles (GUVs). GUVs were freshly prepared by 
electroformation (Vesicle Prep Pro, Nanion 
Technologies) with 10 mM 
diphyntanoylphosphatidylcholine (DPhPC, Avanti 
lipids) and 1 mM cholesterol (Avanti lipids). Lipid 
bilayers were then formed by adding GUVs 
directly into the Port-a-Patch recording chamber 
(Nanion Technologies). After seal formation (> 5 
GΩ), ramp and constant voltage protocols were 
applied for 5–10 min to monitor seal stability and 
exclude the presence of contaminations. DDM-
purified hTRPV3 (0.2–1 µl of 0.5 µg⋅ml-1) was 
then added to the planar lipid bilayer and 
incubated for 5 minutes. First, a ramp voltage 
protocol was applied (-100 to 100 mV in 2 s) to 
assess channel activity. Then, single-channel 
recordings were performed at constant holding 
potentials (different voltages). To exclude possible 
ligand- or vehicle-induced artifacts, we tested all 
ligands (2-APB, camphor, menthol, icilin and 
eucalyptol) in control experiments on mock 
bilayers (no hTRPV3 present). All current 
recordings were terminated upon addition of 
ruthenium red to verify current block. Data were 
recorded at room temperature (21–26 °C). The 
recording solutions contained: 200 mM KCl, 10 
mM HEPES, pH 7.0 (internal) and 200 mM NaCl, 
10 mM HEPES, pH 7.0 (external). The data were 
recorded at a sampling rate of 20 kHz, low-pass 
filtered at 2 kHz (HEKA amplifier) and analyzed 
with Clampfit 10 (Molecular Devices) and Prism 6 
(GraphPad). 
Intrinsic tryptophan fluorescence quenching 
assay– Fluorescence quenching experiments were 
performed at room temperature (21–26 °C) using a 
FlexStation 3 microplate reader (Molecular 
Devices). Seven mutant channels (W433Y, 
W481Y, W493Y, W521Y, W559Y, W692Y and 
W710Y) were synthesized using a QuikChange 
strategy (Stratagene) and verified by sequencing 
(LGC Genomics). The mutants were expressed 
and purified as described above. Freshly purified 
wild type or mutant hTRPV3 (~1 mg⋅ml-1) was 
excited at 295 nm and emission spectra were 
recorded between 320 and 370 nm. To correct for 
background signal, control spectra were recorded 
from separate wells containing buffer + DMSO + 
ligand. The fluorescence peak for wild type 
hTRPV3 was observed near 336 nm, which was 
used as emission wavelength for calculating the 
quenching plots. The quenched fluorescence was 
plotted as F/F0, where F0 and F are the 
fluorescence peak amplitude in the absence and 
presence of ligand, respectively. Lysozyme (~1 
mg⋅ml-1) was used in control experiments to 
evaluate for potential nonspecific quenching 
effects. To calculate KD values, quenched fractions 
(1 - F/F0) were plotted against concentration and 
fit with nonlinear regression using Prism 6 
(GraphPad). Fluorescence quenching experiments 
were performed in the absence or presence of 0.1–
3 mM menthol, 0.1–10 mM camphor, 0.1–10 mM 
1,8-cineole (eucalyptol), 0.1–10 mM 2-
aminoethoxy-diphenyl borate (2-APB) or 0.01–1 
mM icilin. All ligands were freshly diluted to a 
final concentration from frozen stock solutions in 
DMSO. Because of poor solubility, aqueous 
solutions with concentrations higher than 10 mM 
camphor or 3 mM menthol could not be 
completely dissolved. All data represent mean ± 
standard error. Statistical comparisons were made 
using unpaired t test. 
 
RESULTS 
Protein expression and purification – Human 
TRPV3 (hTRPV3) was expressed in Sf9 insect 
cells as a fusion with C-terminal green fluorescent 
protein (GFP). To evaluate the effect of the GFP 
fusion on the functional integrity of hTRPV3, we 
performed calcium imaging experiments (Figure 1 
A-B). When insect cells were challenged with 
camphor, a TRPV3 agonist, the internal calcium 
concentration increased reversibly in cells that 
exhibit GFP fluorescence. In contrast, non-
infected cells (no GFP fluorescence) remained 
unresponsive to the ligand. These results indicate 
that the channel is functional and suggest that the 
GFP fusion does not impede channel hTRPV3 
activity. 
Extraction of a membrane protein from the 
membrane into an aqueous solution requires the 
use of detergents, which shield the hydrophobic 
surface of the protein. However, most detergent-
solubilized membrane proteins tend to aggregate 
or even denature upon solubilization. Therefore, 
the choice of detergent is critical for maintaining 
the protein solubilized in its native oligomeric 
state. In order to find suitable buffer conditions to 
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solubilize hTRPV3, we set up a broad detergent 
screen. We employed the Fluorescence-detection 
Size-exclusion Chromatography (FSEC) assay 
(38) to rapidly analyze the effects of detergents on 
analytical samples of crude membranes. Figure 1C 
shows a selection of the eleven tested detergents. 
DM, DDM, LDAO, LMNG, Fos-10, -12 and -14 
all extracted hTRPV3-GFP from the membrane, 
albeit with varying degrees of success. From these 
detergents, only DM, DDM and LDAO retained 
the protein in a monodisperse state, as indicated by 
the symmetric main peak eluting between void 
volume and free GFP. The retention volume of the 
peak suggests that hTRPV3-GFP eluted as a 
tetramer. From the latter three detergents, DDM 
reached the highest extraction efficiency (i.e. the 
highest peak amplitude) and was therefore selected 
as detergent to pursue purification of hTRPV3.  
We then designed a two-step purification method 
consisting of an immunoaffinity step (GFP trap), 
followed by Size-exclusion chromatography 
(SEC). In the GFP trap (ChromoTek), GFP-
directed nanobodies coupled to agarose beads 
specifically capture the GFP fusion protein. Figure 
2 shows FSEC profiles of solubilized crude 
membranes before incubation with the GFP trap 
(Fig. 2A) and from flow-through of the GFP trap 
(Fig. 2B). The hTRPV3-GFP peak present in 
membrane solubilizate was completely absent in 
flow-through, illustrating the high binding 
efficiency of the trap. For elution, hTRPV3 was 
cleaved from its GFP tag with PreScission 
protease. Then the eluted hTRPV3 was injected on 
a size-exclusion column where it eluted as a single 
sharp peak (Fig. 2C). MS analysis of this eluted 
peak fraction demonstrated the presence of higher 
masses compared to the theoretical mass of 
hTRPV3 (90.6 kDa monomer). This discrepancy is 
still unclear but could be explained by post-
translational modifications inherent to the insect 
cell expression system. To confirm the identity of 
the components of the peak fraction, SDS-PAGE 
gel analysis was done, which showed two major 
bands, corresponding to a slightly lower apparent 
mass than the theoretical mass of hTRPV3 (see 
Fig. 2C). This mass difference could be explained 
by an altered migration of membrane proteins, as 
compared to water-soluble proteins. Therefore, a 
MS-MS approach was performed to identify the 
protein content of both bands. The applied method 
was based on an in-gel digestion with trypsin and 
extraction of the proteolytic peptides followed by 
MS-MS analysis on a MALDI-TOF-TOF 
instrument (Applied Biosystems 4800 MALDI-
TOF-TOF). The analysis confirmed the identity 
hTRPV3 as a single protein in the bands, with 
Mascot scores of 44–59. Western blot of the two 
bands with goat polyclonal anti-TRPV3 IgG 
(Santa Cruz Biotechnology) further confirmed this 
identification (see Fig. 2C). The average yield for 
this purification protocol was ~0.5 mg protein per 
liter of Sf9 culture. 
We then used the FSEC thermo-stability approach 
developed by Hattori et al. to screen for additives 
that favor membrane protein stability in an 
aqueous buffer (39). In this assay, samples of 
solubilized membrane protein are heated in the 
presence and absence of potential stabilizing 
agents, such as lipids, ligands or detergents. First, 
we analyzed hTRPV3 FSEC profiles over a range 
of temperatures and found a melting temperature 
of 36.1 ± 1.0 °C (Fig. 3A). Next, we screened over 
30 different additives (see experimental 
procedures), and found one compound that clearly 
benefits hTRPV3 thermostability. Pre-incubation 
of DDM-solubilized hTRPV3 with the steroid-
derived detergent CHAPS roughly tripled the 
fluorescence peak amplitude of heated sample 
(Fig. 3B). This result is remarkable, as CHAPS 
was found unable to extract hTRPV3 in the 
detergent screen, but now clearly exerts a 
stabilizing effect on DDM-solubilized hTRPV3. 
We then tested a range of CHAPS concentrations 
(0.1–1% (w/v)) and found that 0.2% (w/v) is the 
optimal concentration for thermo-stability 
(CMCCHAPS = 0.49% (w/v)). We therefore added 
CHAPS 0.2% (w/v) to DDM in the purification of 
hTRPV3 for crystallization trials. Preliminary 
crystallization trials yielded dozens of crystals in 
various crystallization conditions. Unfortunately, 
none of these crystals exhibited satisfactory 
diffraction of X-ray light for structure 
determination. Further efforts to improve 
diffraction quality, including protein engineering, 
relipidation and in meso crystallization are 
currently ongoing. 
Reconstitution and patch clamp experiments – 
Although the SEC profile provided strong 
indications that hTRPV3 elutes as a monodisperse 
tetrameric protein, it is essential to determine 
whether detergent-purified hTRPV3 retained its 
functional integrity. We therefore reconstituted 
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purified protein in planar lipid bilayers (DPhPC + 
10% cholesterol) and performed patch clamp 
experiments. Figure 4A shows a ramp voltage 
protocol (-100 to 100 mV in 2 s) applied on a 
bilayer containing a high number of inserted 
proteins. Current responses after addition of 100 
µM 2-APB had a reversal potential close to zero (-
1.52 ± 0.03 mV, n=3). We then reduced the 
amount of purified hTRPV3 added to the bilayers 
to record single-channel openings. Figure 4B 
shows representative single-channel recordings at 
a constant voltage of 50 and 100 mV in the 
presence of 100 µM 2-APB and their 
corresponding current amplitude histograms. The 
histograms were fitted with Gaussian curves, 
yielding mean single-channel current amplitudes 
of 8.4 ± 0.7 and 17.9 ± 0.2 pA at 50 and 100 mV, 
respectively, which corresponds to a single-
channel conductance of 174 pS. Importantly, 
addition of TRPV channel inhibitor ruthenium red 
to 2-APB-activated channels drastically reduced 
channel opening, providing evidence that the 
ligand-induced current is indeed the result of 
reconstituted TRPV3 (Fig. 4C). Then we tested a 
variety of known TRPV3 ligands to explore 
possible alterations in sensitivity of the detergent-
purified channel. Figure 4D shows representative 
current traces of hTRPV3 activation in bilayers by 
2-APB (100 µM), menthol (200 µM), camphor 
(500 µM), and eucalyptol (500 µM) and inhibition 
of 2-APB-evoked current by icilin (10 µM). These 
ligands all elicited the expected functional effects 
on reconstituted hTRPV3. Control experiments on 
bilayers without hTRPV3 showed that neither 
ligand, nor DMSO induced artifacts on the 
bilayers itself. To monitor the concentration range 
in which the agonists activate the channel, we 
plotted the open probability (Po) against applied 
concentration (see Fig. 4E).  
Quenching of intrinsic tryptophan fluorescence – 
Human TRPV3 harbors 11 tryptophan (Trp) 
residues in its entire sequence. These Trp residues 
enable hTRPV3 to fluoresce upon excitation with 
UV light (excitation at 295 nm; emission peak at 
336 nm). We recorded intrinsic fluorescence 
spectra of fresh detergent-purified hTRPV3 in the 
absence and presence of various TRPV3 ligands 
(Fig. 5A–D). While application of 2-APB or 
menthol did not alter the intrinsic fluorescence of 
hTRPV3, increasing concentrations of camphor, 
eucalyptol or icilin progressively quenched the 
fluorescent signal. At saturating concentrations, 
the quenched fraction (Qmax) was 41 ± 8% for 
camphor and 40 ± 2 % for eucalyptol, whereas 
icilin quenched hTRPV3 almost to completion 
with a Qmax of 86 ± 3%. Quenching plots were 
constructed and fitted, yielding dissociation 
constants (KD) of 4.78 ± 1.38 mM for camphor, 
0.28 ± 0.09 mM for eucalyptol and 0.09 ± 0.02 
mM for icilin. This quenching could be caused 
either by ligand binding, by ligand-induced 
degradation of the protein, or a combination of 
both. To investigate a possible scenario of ligand-
induced degradation, we pre-incubated hTRPV3 
with saturating concentrations of camphor (10 
mM) or icilin (1 mM) and analyzed protein 
stability on size-exclusion chromatography and 
SDS-PAGE. For both ligands, no significant 
difference was observed between pre-treated 
hTRPV3 and control, neither in quantity nor in 
monodispersity of the sample, ruling out ligand-
induced degradation. We then evaluated potential 
non-specific quenching by camphor, eucalyptol 
and icilin using lysozyme as a control (Fig. 5E). 
No alteration of lysozyme intrinsic fluorescence 
was observed, indicating that the quenching of 
hTRPV3 by these ligands is specific. Next, we set 
out to identify individual Trp residues involved in 
hTRPV3 quenching by camphor and icilin. We 
introduced single point mutations at seven 
different Trp residues across the transmembrane 
region of hTRPV3: W433Y, W481Y, W493Y, 
W521Y, W559Y, W692Y and W710Y (see Fig. 
6). Due to defective expression or poor yield, we 
were only able to purify and examine mutants 
W481Y, W559Y and W710Y. None of these 
mutants exhibited a significant difference (p > 
0.05) in maximal quenched fraction (Qmax), nor 
in KD, with wild type hTRPV3, indicating that 
Trp481, Trp559 and Trp710 in hTRPV3 are not 
involved in the quenching caused by camphor and 
icilin (see Fig. 5F). This result also implies that the 
quenching-sensitive Trp residues are likely among 
the mutations that were not tolerated. 
 
DISCUSSION 
Structural studies of eukaryotic membrane 
proteins are very challenging. This is mainly due 
to the generally low expression levels and unstable 
behavior of these amphiphilic proteins after 
membrane extraction and purification into aqueous 
buffers. Here, we describe a new efficient protocol 
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for biochemical purification of human TRPV3 that 
utilizes a C-terminal green fluorescent protein 
(GFP) fusion. The GFP fusion serves different 
purposes throughout the purification pipeline: (i) 
during expression, green fluorescence indicates 
that GFP is properly folded, which implies proper 
folding of the TRP channel on the N-terminal side 
of the fusion protein. (ii) During the detergent 
screen and purification process, the GFP fusion 
allows sensitive and selective monitoring of the 
protein of interest and rapid evaluation of the 
monodispersity on analytical samples of non-
purified material on FSEC. (iii) GFP is used as a 
purification tag in the immunoaffinity step of 
purification, allowing high binding specificity that 
results in high sample purity. In this way, the 
purification protocol described here can be 
employed as an extension of the fluorescence-
detection size-exclusion chromatography (FSEC) 
pre-crystallization screening strategy published by 
Kawate and Gouaux (38). 
A recent study by Kol et al. reported the 
purification and functional reconstitution of 
human TRPV3 expressed in E. coli (40).  Despite 
fundamental differences in protein expression and 
processing between human and prokaryote cells, 
they succeeded in obtaining high yields of 
functionally active protein. The biochemical 
properties of the protein however, seem to differ 
significantly from our study, where human TRPV3 
is expressed in a eukaryote host system. A striking 
difference is the inability of DDM to extract and 
solubilize hTRPV3 expressed in bacteria. DDM is 
one of the most commonly used detergents in 
membrane protein chemistry and our detergent 
screen indicates that this detergent yields the best 
results out of eleven tested detergents. By contrast, 
the prokaryote-expressed hTRPV3 was solubilized 
with fos-choline-12, which, in our study, results in 
breakdown of the tetrameric hTRPV3 into 
multiple oligomeric states as evidenced by the 
multiple peaks in the FSEC profile. Moreover, 
native PAGE analysis indicated that hTRPV3 
purification with fos-choline-12 results in 
formation of dimers and tetramers in solution and 
that both species are in equilibrium (40). Although 
the insect cell expression has a significantly lower 
yield compared to a bacterial host system (~0.5 vs. 
~1.2 mg per liter culture) (40), it is still more than 
adequate to provide milligram quantities of 
purified protein necessary for crystallization 
purposes. Moreover, the efficient two-step 
purification protocol presented here yields 
monodisperse protein retaining functional 
integrity. Using planar patch clamp, we recorded 
2-APB-induced currents from reconstituted 
hTRPV3 in lipid bilayers, with a single-channel 
conductance of 174 pS. This value fits very well in 
the range (147–197 pS) from previous reports of 
hTRPV3 expressed in CHO-K1 and HEK293 cells 
(4, 34). Other thermo TRP channels have been 
successfully reconstituted into artificial bilayers, 
yielding crucial functional insights. This way, 
TRPV1, TRPM8 and TRPA1 were shown to be 
intrinsically sensitive to temperature and chemical 
stimuli (41-43). The availability of functional, 
detergent-purified hTRPV3 now offers 
opportunities to further expand our current 
knowledge on gating and modulation of thermo 
TRPs. 
So far, preliminary crystallization trials with 
hTRPV3 have only yielded crystals with 
unsatisfactory diffraction of X-ray light for 
structure determination. It is possible that failure 
to obtain well diffracting crystals is in part due to 
the purification protocol used. For instance, 
possible post-translational modifications inherent 
to the insect expression host or enzymatic removal 
of the C-terminal GFP fusion might contribute to 
sample heterogeneity. Another possible cause for 
poor diffraction of X-ray light is the presence of 
flexible or disordered regions in the protein. Even 
small differences in the primary structure can 
make the difference between a protein that will 
crystallize well and one that will not (44). Our 
future crystallization efforts will therefore focus 
on protein engineering to find minimal functional 
hTRPV3 constructs with as little flexible regions 
as possible, much alike the minimal functional 
constructs designed for the cryo-EM structures of 
rat TRPV1 (32). 
We employed detergent-purified hTRPV3 in 
fluorescence spectroscopy measurements. 
Fluorescence methods can be used to study protein 
conformation and ligand binding through 
quenching of the intrinsic protein fluorescence 
(45, 46). This intrinsic fluorescence is mainly 
derived from tryptophan side chains in the protein 
which act as fluorophores (47). Since the optical 
activity of these fluorophores is strongly 
influenced by their local environment in the 
protein, they make very useful probes to study 
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macromolecular conformation, yielding unique 
information that is not available from other 
functional (e.g. electrophysiological) data. We 
used Trp fluorescence spectroscopy to study the 
interaction of detergent-purified hTRPV3 with 
five different modulators: activators 2-APB, 
camphor, eucalyptol and menthol, and inhibitor 
icilin. While 2-APB and menthol did not alter the 
intrinsic fluorescence of hTRPV3, camphor and 
eucalyptol caused strong quenching (~40 % 
quenched at saturating concentrations) and icilin 
quenched the fluorescence almost to completion. 
The dissociation constant (KD) by which camphor 
quenches hTRPV3 fluorescence (4.78 ± 1.38 mM) 
fits well in the range of reported camphor EC50 
values on transiently expressed TRPV3 (2–7 mM) 
(19, 48). Unfortunately, no EC50 data are available 
for eucalyptol activation of TRPV3. In the case of 
icilin, our measured KD value is one order of 
magnitude higher than the reported IC50 value 
(0.09 ± 0.02 mM vs. 7 ± 2 µM) (22). However in 
this case, comparison is somewhat complicated. 
Firstly, the reported IC50 describes the inhibition 
of 2-APB-evoked TRPV3 currents by icilin, while 
the KD value represents icilin quenching in the 
absence of 2-APB, or any other agonist. Moreover, 
the reported IC50 value was established in mouse 
TRPV3, while we determined the KD value in 
human TRPV3 (22). In the same paper, the authors 
also tested human TRPV3 and found that 
significantly higher icilin concentrations were 
required for current inhibition, compared to the 
mouse ortholog. Although a concentration-
response relationship was not determined for 
human TRPV3, the lower apparent sensitivity for 
icilin indicates that the IC50 on human TRPV3 
may be closer to our KD value than the IC50 on 
mouse TRPV3 is. 
To investigate whether the lack of quenching by 
menthol and 2-APB could be due to a diminished 
sensitivity of the purified protein, we characterized 
these ligands on reconstituted hTRPV3 in bilayers.  
All ligands produced the expected functional 
effects in the concentration range from 
observations in transiently expressed TRPV3 (21, 
22, 34, 48, 49).Next, we excluded a scenario of 
ligand-induced degradation contributing to the 
quenching induced by camphor, eucalyptol or 
icilin and demonstrated the specific character of 
the observed quenching using lysozyme as a 
control. Moreover, the lysozyme intrinsic 
fluorescence was not altered in the presence of 
camphor, eucalyptol or icilin, indicating that these 
ligands do not absorb light at the excitation or 
emission wavelengths. Together, these controls 
draw us to conclude that the quenching occurs 
either as a direct result (Trp residues in or near the 
ligand binding site) or an indirect result (through 
conformational change) of ligand binding. 
To dissect the observed quenching into 
contributions from individual Trp residues, we 
point-mutated tryptophan into tyrosine residues. 
Such a mutation retains the approximate size and 
aromatic character of the residue, but eliminates 
fluorescence at the measured wavelength. Because 
several mutational studies appointed the pore 
region, transmembrane (TM) domain and TRP 
domain to be involved in the interaction of icilin 
and terpenoids with TRP channels (50-53), we 
focused our attention on the seven tryptophan 
chains residing in this part of hTRPV3 (see Fig. 
6). Due to defective expression or low yield, we 
were only able to analyze W481Y, W559Y and 
W710Y for quenching by camphor or icilin. The 
maximal quenched fraction and dissociation 
constants of all three mutants were similar to wild 
type hTRPV3, indicating that Trp481, Trp559 and 
Trp710 are not involved in the quenching by 
camphor and icilin. A simple but clear conclusion 
is that neither of these residues are directly 
involved in binding of camphor and icilin, and that 
these positions are not affected by ligand-induced 
conformational changes. 
Our data illustrate that 2-APB and camphor exert 
distinct mechanisms of action on hTRPV3. This is 
supported by a mutation study which showed that 
two residues in mouse TRPV3 (His426 and Arg696) 
are crucial for sensitivity to 2-APB, but not to 
camphor (48). It was also reported that long-term 
(5–15 min) incubation with terpenoid ligands like 
camphor, leads to desensitization of TRPV3, 
whereas 2-APB sensitizes channel activity (35). 
In spite of their structural relatedness, camphor 
and menthol display a remarkable difference in 
quenching behavior. Camphor was previously 
shown to interact with a conserved cysteine 
residue (Cys619) in the pore region of mouse 
TRPV3 (53). Mutation of this residue resulted in 
total loss of camphor sensitivity, while responses 
to 2-APB and dihydrocarvacrol remained 
untouched. Unfortunately, the recently published 
cryo-EM structures of rat TRPV1 depict a minimal 
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functional construct in which, among other, pore-
region residues 604–626 are deleted (32). This 
makes it difficult to imagine the exact spatial 
location of Cys619, but if this residue would indeed 
take part in a camphor binding site, this site would 
be distant from any Trp residue in TRPV3. 
However, camphor clearly quenches hTRPV3 
tryptophan fluorescence in our study. This 
suggests that the quenching by camphor is a result 
of an indirect (due to a conformational change), 
rather than a direct effect (ligand binding). The 
complete absence of quenching by menthol, on the 
other hand, does not necessarily imply that 
menthol occupies a different binding site on 
hTRPV3 than camphor. Because of their structural 
relation, it is conceivable that menthol would bind 
to a similar site on hTRPV3. In a functional study, 
TRPV3 agonists were classified into three groups, 
based on their pharmacological profile (35). A first 
category includes agonists like 2-APB that do not 
induce desensitization of TRPV3. The two other 
categories consist of agonists that cause different 
types of desensitization upon long-term exposure. 
The bicyclic terpenoids (e.g. camphor and 
eucalyptol) induce acute desensitization, while the 
monocyclic terpenoids (e.g. menthol and 
dihydrocarveol) cause tachyphylaxis. Taking a 
conformational change at the basis of camphor and 
eucalyptol quenching in mind, the difference in 
quenching between camphor/eucalyptol and 
menthol could illustrate the distinct functional 
behavior of the two classes of terpenoids. Indeed, 
during the fluorescence recordings, protein 
samples were incubated with ligands in a time 
scale that would allow desensitization to occur (> 
5 min). It appears that quenching may be 
associated with negative functional effects i.e. 
inhibition by icilin and desensitization by camphor 
and eucalyptol. 
A remarkable observation is the extensive 
quenching exercised by icilin, which almost 
completely extinguished hTRPV3 fluorescence. 
This dramatic change indicates major structural 
rearrangements in TRPV3 upon icilin binding. 
Icilin sensitivity in TRPM8 is thought to be 
mediated through residues in the intracellular loop 
connecting TM2 and TM3 (50). These residues 
correspond to an analogous region in TRPV1 
believed to be important for capsaicin sensitivity 
(54). Similarly, residues in TM2, TM3 and TM4 
were pointed out as crucial determinants for 
menthol activation of TRPM8, and for activation 
of TRPV4 by 4α-phorbol esters (51, 52, 55). It 
was proposed that menthol possibly intercalates 
between TM2 and TM4 to activate TRPM8. In a 
more general mechanism, TRP channel ligands 
were proposed to shift the voltage dependence of 
channel activation through interaction with TM1–
TM4 (52). Although it does not reveal information 
about a possible binding site, the difference in 
quenching between menthol and icilin on hTRPV3 
might reflect the inverse functional effect of icilin 
on this channel. In another model, ligand binding 
is mechanically coupled to channel opening 
through the TRP domain, which is involved in 
translating the initial ligand-binding event to the 
allosteric conformational changes that cause 
channel opening (51). Such a model would be less 
evident in our data, as mutation of Trp710, which is 
adjacent to the TRP domain, does not change 
quenching in hTRPV3. 
In conclusion, our data confirm and expand the 
hypothesis that TRPV ion channels are 
allosterically modulated by different chemical 
ligands through independent and distinct 
molecular mechanisms. It is however clear that 
high-resolution structures will be required to 
validate and establish ligand binding sites and to 
help unravel the mechanisms that underlie gating 
in TRP channels. The TRPV3 purification 
protocol presented here provides a crucial step 
towards high-resolution structure elucidation.
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diphyntanoyl phosphatidylcholine; DRG, dorsal root ganglia; Fos-10 (-12, -14), decyl (dodecyl, 
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giant unilamellar vesicle; (h)TRPV(3), (human) transient receptor potential vanilloid (member 3); LDAO, 
lauryl dimethylamine oxide; LMNG, lauryl maltoside neopentyl glycol; TM, transmembrane segment; 
TRPA, TRP ankyrin; TRPM, TRP melastatin 
 
 
FIGURE LEGENDS 
 
Figure 1 – Expression and detergent screen of human TRPV3. (A) Sf9 cells infected with recombinant 
baculovirus (top left), exposed to blue light to monitor GFP fluorescence (top right), and in the absence 
and presence of 10 mM camphor during a calcium imaging experiment (bottom left and right, 
respectively). (B) Calcium imaging experiment, showing the response of Sf9 cells expressing hTRPV3-
GFP (red) and control (black) to 10 mM camphor. The dashed lines represent mean ± SEM (n=52). (C) 
Detergent screen of hTRPV3. Graph shows a superposition of FSEC profiles from detergent-solubilized 
hTRPV3-GFP. Comparison of peak amplitude and symmetry between different detergents reveals the 
superior extraction efficiency and stability of hTRPV3-GFP in DDM. 
 
Figure 2 – Purification of human TRPV3. (A) FSEC profile of solubilized Sf9 membranes expressing 
hTRPV3-GFP (analytical sample taken before incubation with GFP trap). (B) FSEC profile of analytical 
sample from the flow-through from the same GFP trap. (C) UV-detection SEC profile of hTRPV3 after 
elution from the GFP trap. Inset shows a Coomassie-stained SDS gel and western blot of the hTRPV3 
peak fraction, carried out with goat polyclonal anti-TRPV3 IgG. 
 
Figure 3 – Thermostability-based FSEC screening for hTRPV3-stabilizing additives. (A) Melting curve of 
hTRPV3-GFP, yielding a melting temperature (i.e. the temperature at half-maximal fluorescence 
amplitude) of 36.2 ± 1.0 °C. Relative fluorescence is calculated from oligomeric peak amplitudes in 
consecutive FSEC runs with hTRPV3-GFP samples, pre-heated at different temperatures. Data represent 
mean ± SEM (n=3). Inset shows an overlay of the oligomeric peak FSEC profiles. (B) Bar diagram shows 
relative fluorescence of oligomeric peak amplitudes from consecutive FSEC runs with a selection of 
additives tested for possible stabilizing effects on hTRPV3-GFP. Black and gray bars represent relative 
FSEC peak amplitudes of hTRPV3-GFP without additives, incubated at 4 and 40 °C, respectively (with 
control 4 °C set as 1). Blue bars represent relative peak amplitudes of hTRPV3-GFP samples 
supplemented with various additives before incubation at 40 °C. 
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Figure 4 – Functional reconstitution of purified hTRPV3. (A) Representative current recording from a 
planar lipid bilayer containing a high number of hTRPV3 channels during a ramp voltage protocol from -
100 to 100 mV. Arrows indicate the traces before (control) and after addition of 100 µM 2-APB. Dashed 
line indicates the zero current level. (B) Representative current traces of single-channel activity recorded 
from a planar lipid bilayer clamped at 50 and 100 mV after addition of 100 µM 2-APB (left). Closed 
channel current level is indicated by dashed lines. Corresponding current amplitude histograms (right), 
yielding a single-channel conductance of 174 pS. (C) Representative current trace from a lipid bilayer 
containing multiple hTRPV3 channels recorded at 100 mV. The channels were activated by 100 µM 2-
APB, and subsequently inhibited by 10 µM ruthenium red. The arrow indicates where ruthenium red was 
added. (D) Representative current traces of single-channel activity recorded at 100 mV in the presence of 
100 µM 2-APB, 200 µM menthol, 500 µM camphor or 500 µM eucalyptol. The bottom trace shows 
inhibition of 2-APB-activated current by 10 µM icilin. The arrow indicates where icilin was added. (E) 
Scatter plot showing open probability (Po) versus applied concentration of the tested agonists. 
 
Figure 5 – Quenching of intrinsic tryptophan (Trp) fluorescence by TRPV3 ligands. Graphs show 
averaged fluorescence emission spectra (n=3) of hTRPV3 in the presence of increasing concentrations 2-
APB (A), menthol (B), camphor (C) and icilin (D). (E) Quenching plots of hTRPV3 and lysozyme in the 
presence of camphor, eucalyptol and icilin show that the hTRPV3 quenching by these compounds is 
specific. (F) Bar diagram compares the quenching of wild type hTRPV3 with Trp mutants, recorded in 
the presence of a saturating concentration of camphor (10 mM) and icilin (1 mM). All data represent 
mean ± SEM (n=3). None of the tested mutants exhibits a significant difference with wild type hTRPV3 
in Qmax value (p > 0.05). 
 
Figure 6 – Conservation and spatial location of tryptophan (Trp) residues in TRPV channels. (A) 
Sequence alignment of the human thermo-sensitive TRPV channels. Rat TRPV1 (rTRPV1) is included 
for comparison with cryo-EM structure in (B). Trp residues in the transmembrane region of hTRPV3 are 
colored yellow, homologous positions in rTRPV1 are shown in red. (B) Cartoon representations of the rat 
TRPV1 Cryo-EM structure (32), seen along the four-fold symmetric axis (top left) and in side view 
(bottom left). Ball-and-stick representations depict rTRPV1 residues, homologous to Trp residues in 
hTRPV3. Numbers corresponding to Trp residues in hTRPV3 are shown in yellow, numbers 
corresponding to residues in homologous positions in rTRPV1 are shown in red. 
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Figure 3 
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